Challenges and advances in serological and molecular tests to aid leprosy diagnosis

被引:2
|
作者
Lopes-Luz, Leonardo [1 ,2 ]
Saavedra, Djairo Pastor [1 ,2 ]
Fogaca, Matheus Bernardes Torres [1 ,2 ]
Buhrer-Sekula, Samira [1 ,2 ]
Stefani, Mariane Martins de Araujo [1 ,2 ]
机构
[1] Univ Fed Goias, Inst Patol Trop & Saude Publ, Lab Desenvolvimento & Prod Testes Rapidos, BR-74605050 Goiania, Brazil
[2] UFG Merck SA Alliance, Innovat Hub Point Care Technol, BR-74690900 Goiania, Brazil
关键词
Leprosy; diagnosis; PGL-I; LID-1; point-of-care testing; RLEP gene; MYCOBACTERIUM-LEPRAE; CHEMICAL-SYNTHESIS; PROTEIN ANTIGENS; DIPSTICK ASSAY; SERUM-ALBUMIN; FLOW TEST; PGL-I; RISK; CLASSIFICATION; HISTOPATHOLOGY;
D O I
10.1177/15353702231209422
中图分类号
R-3 [医学研究方法]; R3 [基础医学];
学科分类号
1001 ;
摘要
Leprosy is a neglected chronic infectious disease caused by obligate intracellular bacilli, Mycobacterium leprae and Mycobacterium lepromatosis. Despite multidrug therapy (MDT) success, leprosy accounts for more than 200,000 new cases yearly. Leprosy diagnosis remains based on the dermato-neurologic examination, but histopathology of skin biopsy and bacilloscopy of intradermal scraping are subsidiary diagnostic tests that require expertise and laboratory infrastructure. This minireview summarizes the state of the art of serologic tests to aid leprosy diagnosis, highlighting enzyme-linked immunosorbent assay (ELISA) and point-of-care tests (POCT) biotechnologies. Also, the impact of the postgenomic era on the description of new recombinantly expressed M. leprae-specific protein antigens, such as leprosy Infectious Disease Research Institute (IDRI) diagnostic (LID)-1 is summarized. Highly specific and sensitive molecular techniques to detect M. leprae DNA as the quantitative polymerase chain reaction (qPCR) and the loop-mediated isothermal amplification (LAMP) are briefly reviewed. Serology studies using phenolic glycolipid-I (PGL-I) semi-synthetic antigens, LID-1 fusion antigen, and the single fusion complex natural disaccharide-octyl (NDO)-LID show high sensitivity in multibacillary (MB) patients. However, serology is not applicable to paucibacillary patients, as they have weak humoral response and robust cell-mediated response, requiring tests for cellular biomarkers. Unlike ELISA-based tests, leprosy-specific POCT based on semi-synthetic PGL-I antigens and NDO-LID 1 antigen is easy to perform, cheaper, equipment-free, and can contribute to early diagnosis avoiding permanent incapacities and helping to interrupt M. leprae transmission. Besides its use to help diagnosis of household contacts or at-risk populations in endemic areas, potential applications of leprosy serology include monitoring MDT efficacy, identification of recent infection, especially in young children, as surrogate markers of disease progression to orient adult chemoprophylaxis and as a predictor of type 2 leprosy reactions. Advances in molecular biology techniques have reduced the complexity and execution time of qPCR confirming its utility to help diagnosis while leprosy-specific LAMP holds promise as an adjunct test to detect M. leprae DNA.
引用
收藏
页码:2083 / 2094
页数:12
相关论文
共 50 条
  • [41] A study on the methods for early serological diagnosis of leprosy and their potential use
    Wu, QX
    Li, XY
    Yin, YP
    Shu, HW
    Wei, WH
    Liu, Q
    Ye, GY
    INTERNATIONAL JOURNAL OF LEPROSY AND OTHER MYCOBACTERIAL DISEASES, 1999, 67 (03) : 302 - 305
  • [42] Advances in the molecular and serological diagnosis of invasive fungal infection in haemato-oncology patients
    McLintock, LA
    Jones, BL
    BRITISH JOURNAL OF HAEMATOLOGY, 2004, 126 (03) : 289 - 297
  • [43] How recent advances in molecular tests could impact the diagnosis of pneumonia
    Murdoch, David R.
    EXPERT REVIEW OF MOLECULAR DIAGNOSTICS, 2016, 16 (05) : 533 - 540
  • [44] A STUDY ON PERFORMANCE OF 2 SEROLOGICAL ASSAYS FOR DIAGNOSIS OF LEPROSY PATIENTS
    PARKASH, O
    CHATURVEDI, V
    GIRDHAR, BK
    SENGUPTA, U
    LEPROSY REVIEW, 1995, 66 (01) : 26 - 30
  • [45] Recent advances and challenges of biosensing in point-of-care molecular diagnosis
    Chu, Hongwei
    Liu, Conghui
    Liu, Jinsen
    Yang, Jiao
    Li, Yingchun
    Zhang, Xueji
    SENSORS AND ACTUATORS B-CHEMICAL, 2021, 348
  • [46] SEROLOGICAL MARKERS AS AN AID IN THE DIAGNOSIS OF VIRAL-INFECTIONS
    MORAG, A
    ISRAEL JOURNAL OF MEDICAL SCIENCES, 1983, 19 (10): : 876 - 880
  • [48] Evaluation of different serological tests for the diagnosis of pemphigus
    Vaschieri, C
    Marconi, A
    Pincelli, C
    Giannetti, A
    JOURNAL OF INVESTIGATIVE DERMATOLOGY, 2005, 125 (05) : 1092 - 1092
  • [49] SEROLOGICAL TESTS IN DIAGNOSIS OF PRIMARY BILIARY CIRRHOSIS
    WALKER, JG
    DONIACH, D
    ROITT, IM
    SHERLOCK, S
    LANCET, 1965, 1 (7390): : 827 - +
  • [50] SEROLOGICAL TESTS IN DIAGNOSIS OF PRIMARY BILIARY CIRRHOSIS
    WEIR, DM
    PINCKARD, RN
    LANCET, 1965, 1 (7393): : 1016 - &